The high specific strength, good corrosion resistance, and great biocompatibility make titanium and its alloys the ideal materials for biomedical metallic implants. Ti-6Al-4V alloy is the most employed in practical biomedical applications because of the excellent combination of strength, fracture toughness, and corrosion resistance. However, recent studies have demonstrated some limits in biocompatibility due to the presence of toxic Al and V. Consequently, scientific literature has reported novel biomedical β-Ti alloys containing biocompatible β-stabilizers (such as Mo, Ta, and Zr) studying the possibility to obtain similar performances to the Ti-6Al-4V alloys. The aim of this review is to highlight the corrosion resistance of the passive layers on biomedical Ti-6Al-4V and β-type Ti alloys in the human body environment by reviewing relevant literature research contributions. The discussion is focused on all those factors that influence the performance of the passive layer at the surface of the alloy subjected to electrochemical corrosion, among which the alloy composition, the method selected to grow the oxide coating, and the physicochemical conditions of the body fluid are the most significant.

• Bacterial adhesion to the surface of dental materials play a significant role in infections. • The factors that govern microbial attachment involves different types of physical-chemical interactions and biological processes. • Studying bacterial adhesion makes it possible to understand the mechanisms involved in attachment and helps in the search for technologies that promote antibacterial surfaces.

The aim of this study was to systematically review the literature to investigate whether silver nanoparticles (AgNPs) have an anti-inflammatory effect in vivo. The guidelines of PRISMA were applied, and a registration was made in PROSPERO. A personalized search of the PubMed, Web of Science, Scopus, Embase, Lilacs, and Google Scholar databases was conducted in September 2023. For the data analysis, the inverse variance in the random effects model was used. The tools of SYRCLE and GRADE were used to assess the risk of bias and the certainty of evidence, respectively. From the 9185 identified studies, 5685 duplicate studies were excluded; 52 were read in full text, and 7 were included in this review. Six studies were evaluated by the meta-analysis, and an increase in anti-inflammatory molecules (SMD -5.22; PI [-6.50, -3.94]) and an increase in anti-inflammatory ones (SMD 5.75; PI [3.79, 7.72]) were observed. Qualitative analysis showed a reduction in pro-inflammatory proteins and in the COX-2 pathway. It was concluded that AgNPs present an anti-inflammatory action in vivo through mechanisms involving the reduction of pro-inflammatory molecules and proteins, the increase of anti-inflammatory molecules, and selective inhibition of the COX-2 pathway.